Exenatide necklace | sterling silver If you have spent enough time on type 2 diabetes pharmacology to remember when GLP-1 was a research hormone rather than a billion-dollar therapeutic class, exenatide is the molecule that started it. Isolated from Gila monster saliva by John Eng at the Bronx VA hospital, the first GLP-1 receptor agonist to reach the clinic. Worn here as a 24 mm sterling silver pendant. The Science Behind Exenatide Exenatide is a synthetic version of exendin-4, a 39-amino-acid peptide isolated from the saliva of Heloderma suspectum, the Gila monster. John Eng identified the peptide in the early 1990s while looking for hormones with longer half-lives than endogenous GLP-1, which mammalian dipeptidyl peptidase-4 (DPP-4) degrades within minutes. Exendin-4 shares roughly 53% sequence identity with human GLP-1 but resists DPP-4 degradation, giving it a half-life suitable for clinical use. Exenatide entered the clinic in 2005 as Byetta, the first incretin-mimetic drug for type 2 diabetes. The class has since expanded enormously: liraglutide, dulaglutide, semaglutide (the molecule behind Ozempic and Wegovy), and tirzepatide (a dual GIP/GLP-1 agonist). The modern obesity-pharmacology revolution traces its lineage back to exenatide and the Gila monster venom that started it. A Quiet Symbol For endocrinologists and diabetes specialists obesity medicine physicians and metabolic researchers peptide chemists and pharmacologists working on incretin biology patients on GLP-1 receptor agonist therapy For someone who reaches for exenatide when the conversation is about the original Gila monster discovery, not the latest semaglutide branding. Explore Related Molecules Jewelry Insulin necklace | silver Glucose necklace | gold vermeil Cyclosporine necklace | silver Doxorubicin necklace | silver Quinine necklace | silver FAQ Why exenatide rather than the more famous semaglutide? Because exenatide started the class. Semaglutide and the rest of the GLP-1 family are direct descendants of the original Gila monster discovery. Working diabetes and obesity specialists tend to find exenatide more meaningful as a reference because it represents the foundational pharmacology rather than the most-marketed brand. The pendant carries the original molecule, and the audience that recognises it tends to know exactly why that matters. Why was Gila monster venom such a productive starting point? Because reptile venom peptides are evolved to resist host enzyme degradation, which is exactly the property mammalian GLP-1 lacked for clinical use. John Eng's insight was that an animal whose digestive cycle requires long-acting bioactive peptides might be a natural source for the kind of stable hormone analogues that pharmacology had been trying to engineer. The Gila monster was an unlikely but correct hypothesis. The same general approach (mining venoms and toxins for stable peptides) has turned up captopril (snake venom), ziconotide (cone snail), and several other clinical drugs. What size is the pendant and what chain comes with it? 925 sterling silver, 24 mm pendant on a 45 cm sterling silver chain with a 5 cm extender. Nickel-free and hypoallergenic. Free worldwide DHL Express in 1-5 business days, with all import duties and taxes covered. 30-day “Love It or Return It” returns. Is there a gold version? Not at present. Exenatide is sterling silver only. Other working pharmacology molecules in the catalogue, including cyclosporine and quinine, exist in 18K gold vermeil if a gold molecule from working clinical pharmacology is the goal.
Related
Related
Related
Related